siRNA therapy reduces triglycerides in patients with rare condition

.RESEARCH FEATURE.19 September 2024.

Plozasiran lowered triglyceride amounts through 80% and also decreased the danger of pancreatitis in people with constant chylomicronemia, with or without a genetic prognosis.

Articles You Can Be Interested In

• Public Policy
• Web Development
• Entrepreneurship
• Business
• Local News
• Retail
• Finance
• Management
• Pets
• Public Speaking
• Holidays
• Parenting
• Holidays
• Mental Health
• Nutrition
• Weddings
• Nanotechnology
• Robotics
• Nanotechnology
• Savings